Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6

Atherosclerosis

Volumn 188, Issue 2, 2006, Pages 450-454

  Hulthe, Johannes ^a,b   McPheat, William ^a   Samnegård, Ann ^c   Tornvall, Per ^d   Hamsten, Anders ^e   Eriksson, Per ^e  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Coronary atherosclerosis; IL 18; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 18; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROINSULIN; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INSULIN; INTERLEUKIN-18; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEPHELOMETRY AND TURBIDIMETRY; RISK FACTORS; SWEDEN;

EID: 33748177886     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.013     Document Type: Article

References (24)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Lagrand W.K., Visser C.A., Hermens W.T., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation 100 (1999) 96-102
3. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10
4. Gracie J.A., Robertson S.E., and McInnes I.B. Interleukin-18. J Leukoc Biol 73 (2003) 213-224
5. Okamura H., Tsutsi H., Komatsu T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88-91
6. Blankenberg S., Tiret L., Bickel C., et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106 (2002) 24-30
7. Blankenberg S., Luc G., Ducimetiere P., et al. Interleukin-18 and the risk of coronary heart disease in European men: the prospective epidemiological study of myocardial infarction (PRIME). Circulation 108 (2003) 2453-2459
8. Mallat Z., Corbaz A., Scoazec A., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104 (2001) 1598-1603
9. Aso Y., Okumura K., Takebayashi K., Wakabayashi S., and Inukai T. Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes Care 26 (2003) 2622-2627
10. Eriksson P., Deguchi H., Samnegard A., et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol 24 (2004) 551-557
11. Austen W.G., Edwards J.E., Frye R.L., et al. A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American heart association. Circulation 51 (1975) 5-40
12. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., and Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knockout mice. J Clin Invest 99 (1997) 2752-2761
13. Whitman S.C., Ravisankar P., and Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 90 (2002) E34-E38
14. Elhage R., Jawien J., Rudling M., et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 59 (2003) 234-240
15. Bjorkbacka H., Kunjathoor V.V., Moore K.J., et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signalling pathways. Nat Med 10 (2004) 416-421
16. Hodis H.N., and Mack W.J. Atherosclerosis imaging methods: assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis. Am J Cardiol 89 (2002) 19E-27E [discussion 27E]
17. Blankenhorn D.H., and Hodis H.N. George lyman duff memorial lecture. Arterial imaging and atherosclerosis reversal. Arterioscler Thromb 14 (1994) 177-192
18. Azen S.P., Mack W.J., Cashin-Hemphill L., et al. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the cholesterol lowering atherosclerosis study. Circulation 93 (1996) 34-41
19. Buchwald H., Matts J.P., Fitch L.L., et al. Changes in sequential coronary arteriograms and subsequent coronary events. Surgical control of the hyperlipidemias (POSCH) group. JAMA 268 (1992) 1429-1433
20. Hulthe J., Wikstrand J., Emanuelsson H., Wiklund O., de Feyter P.J., and Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 28 (1997) 1189-1194
21. Laaksonen D.E., Niskanen L., Nyyssonen K., et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia (2004)
22. Escobar-Morreale H.F., Botella-Carretero J.I., Villuendas G., Sancho J., and San Millan J.L. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab 89 (2004) 806-811
23. Dai S.M., Matsuno H., Nakamura H., Nishioka K., and Yudoh K. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum 50 (2004) 432-443
24. Warne J.P. Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J Endocrinol 177 (2003) 351-355